Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective

被引：0
|
作者：
Barbara Fischer
Andreas Serra
Harry Telser
机构：
[1] Polynomics,Department of Internal Medicine and Nephrology
[2] Klinik Hirslanden,Center for Health, Policy and Economics
[3] University of Lucerne,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Chronic kidney disease; Hyperkalemia; Patiromer; Potassium binder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2717 / 2730
页数：13
相关论文
共 50 条
  • [31] Sodium Polystyrene Sulfonate for Secondary Prevention of Hyperkalemia in Patients with Chronic Kidney and Heart Diseases on Renin-Angiotensin-Aldosterone System Blockade Therapy
    Chemin, Gil
    Gal-Oz, Amir
    Schwartz, Idit F.
    Schwartz, Doron
    Silverberg, Donald S.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S107 - S107
  • [32] Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait
    Elsisi, Gihan Hamdy
    Mahmoud, Mohamed M. Ibrahim
    Al-Humood, Khaldoon
    Al-Yousef, Anas
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 253 - 265
  • [33] Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease
    Filev, Rumen
    Rostaing, Lionel
    Lyubomirova, Mila
    Bogov, Boris
    Kalinov, Krassimir
    Svinarov, Dobrin
    MEDICINE, 2022, 101 (48) : E31988
  • [34] Renin-angiotensin-aldosterone system inhibition decreased contrast-associated acute kidney injury in chronic kidney disease patients
    Chen, Yi-Ting
    Chan, Chieh-Kai
    Li, Wen-Yi
    Huang, Tao-Min
    Lai, Tai-Shuan
    Wu, Vin-Cent
    Chu, Tzong-Shinn
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2021, 120 (01) : 641 - 650
  • [35] Patiromer For The Management Of Hyperkalemia In Patients Receiving Renin-Angiotensin-Aldosterone System Inhibitor Medications For Heart Failure With Reduced Ejection Fraction Has No Difference By Sex: Results From The Diamond Trial
    Pina, Ileana L.
    Butler, Javed
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 665 - 665
  • [36] COST-EFFECTIVENESS OF CINACALCET CHRONIC KIDNEY DISEASE PATIENTS ON DIALYSIS WITH SECONDARY HYPERPARATHYROIDISM IN BRAZILIAN PUBLIC HEALTH CARE SYSTEM (SUS)
    Nishikawa, A. M.
    Coutinho, M. B.
    Custodio, M. R.
    Pecoits-Filho, R. F.
    Clark, O. A. C.
    VALUE IN HEALTH, 2013, 16 (07) : A698 - A698
  • [37] A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure
    Thomas Ward
    Ruth D. Lewis
    Tray Brown
    Garth Baxter
    Antonio Ramirez de Arellano
    BMC Nephrology, 24
  • [38] Responses of the renin-angiotensin-aldosterone system in pregnant chronic kidney disease patients with and without superimposed pre-eclampsia
    Kurlak, Lesia O.
    Pipkin, Fiona Broughton
    Mohaupt, Markus G.
    Mistry, Hiten D.
    CLINICAL KIDNEY JOURNAL, 2019, 12 (06) : 847 - 854
  • [39] A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure
    Ward, Thomas
    Lewis, Ruth D.
    Brown, Tray
    Baxter, Garth
    de Arellano, Antonio Ramirez
    BMC NEPHROLOGY, 2023, 24 (01)
  • [40] Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
    Linde, Cecilia
    Bakhai, Ameet
    Furuland, Hans
    Evans, Marc
    McEwan, Phil
    Ayoubkhani, Daniel
    Qin, Lei
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
12345